Financial Performance Summary
Half Year Ended September 2026 (H1 FY27)
Consolidated Performance:
- Total Income: ₹615.54 Million
- Profit After Tax (PAT): ₹32.75 Million (compared to loss of ₹12.13 Million in H1 FY26)
Standalone Performance:
- Total Income: ₹280.52 Million
- Net Profit: ₹31.89 Million (compared to loss of ₹27.83 Million in H1 FY26)
Quarter Ended September 2026 (Q2 FY27)
Consolidated Performance:
- Total Income: ₹298.52 Million
- Revenue from Operations: ₹294.17 Million
- Net Profit: ₹22.12 Million (108.17% quarter-on-quarter growth from ₹10.63 Million in Q1 FY27)
Standalone Performance:
- Total Income: ₹147.55 Million (10.97% quarter-on-quarter growth from ₹132.97 Million in Q1 FY27)
- Net Profit: ₹22.21 Million (129.36% quarter-on-quarter growth from ₹9.68 Million in Q1 FY27)
Strategic Initiatives and Business Updates
Digital Healthcare Platform Launch
- TAKE.Health: Intelligent digital health companion platform launched
- Designed to integrate lifestyle and medical data into personalized, actionable health insights
- Enables users to connect health information, analyze trends, and understand health indicators
- Aims to participate in growing digital health and preventive healthcare ecosystem
Innovation Fund
- ₹50 Million Innovation Fund launched with initial corpus commitment of ₹5 crore
- Focus on identifying, investing in, and supporting high-potential startups
- Target areas: Artificial Intelligence, deep technology, and digital health
- Specific focus areas: AI-powered diagnostics, predictive analytics, longevity sciences, and digital health platforms
- Support includes capital, domain expertise, industry networks, and technology-led capabilities
Market Expansion
- Strategic entry into India's longevity and anti-ageing market
- Plans to develop science-backed nutraceuticals and biohacking-focused products
- Technology-enabled preventive healthcare solutions development
- Approach combines product innovation with digital wellness capabilities
- Solutions to help consumers monitor metabolic health, sleep, cognition, and biological ageing
Future Outlook and Priorities
- Focus on strengthening presence across digital healthcare, preventive wellness, longevity sciences, and technology-enabled healthcare solutions
- Priority areas: Expanding TAKE.Health capabilities, developing longevity and wellness offerings, evaluating Innovation Fund investment opportunities
- Exploring application of AI and advanced technologies across healthcare and life sciences
- Approach emphasizes commercially viable offerings, execution capabilities, leveraging existing domain expertise, and financial discipline
- Growth opportunity evaluation based on market potential, scalability, commercial viability, and contribution to sustainable business performance
Management Commentary
Mr. Sunil Patra, Managing Director, stated: \"The first half of FY2026–27 represents an important period for TAKE Limited as we have made progress in strengthening our financial performance while advancing our strategic priorities. Our return to profitability across consolidated and standalone operations is an encouraging development. We are particularly focused on the convergence of healthcare, science and technology. Initiatives such as TAKE.Health, our Innovation Fund and our strategic entry into the longevity and preventive healthcare segment reflect our ambition to develop businesses that address evolving healthcare needs through innovation and technology. Going forward, our emphasis will be on execution, developing commercially sustainable offerings and building complementary business verticals. We remain focused on strengthening our financial fundamentals, pursuing disciplined growth opportunities and creating sustainable long-term value for our shareholders.\"
Company Background
TAKE Limited is a technology-driven company focused on healthcare, life sciences and emerging technology-enabled solutions. The company is expanding its business interests across digital healthcare, Artificial Intelligence, preventive wellness and longevity sciences, with an emphasis on innovation and technology-led business development.